跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
CUPRIOR trientine (as tetrahydrochloride) 150 mg film-coated tablets - TGA Drug Approval Details
Approvals
/
TGA
/
CUPRIOR trientine (as tetrahydrochloride) 150 mg film-coated tablets
Approved
STANDARD
CUPRIOR trientine (as tetrahydrochloride) 150 mg film-coated tablets
JACE Pharma Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 30, 2025
Approval ID
77f1d49d853cd02e
Company
JACE Pharma Pty Ltd
Type
Standard
Approval Details
Approval Id
77f1d49d853cd02e
Product Name
CUPRIOR trientine (as tetrahydrochloride) 150 mg film-coated tablets
Artg Id
337139
Artg Name
CUPRIOR trientine (as tetrahydrochloride) 150 mg film-coated tablets
Sponsor
JACE Pharma Pty Ltd
Company Detail Path
/organization/jace-pharma-pty-ltd
Artg Date
2021-09-28
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 30, 2025
Approval ID
77f1d49d853cd02e
Type
Standard
Back to TGA Approvals
